A detailed history of First Premier Bank transactions in Amgen Inc stock. As of the latest transaction made, First Premier Bank holds 9,390 shares of AMGN stock, worth $2.7 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
9,390
Previous 9,559 1.77%
Holding current value
$2.7 Million
Previous $2.99 Million 1.31%
% of portfolio
0.75%
Previous 0.8%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$309.38 - $337.38 $52,285 - $57,017
-169 Reduced 1.77%
9,390 $3.03 Million
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $14,451 - $17,562
-55 Reduced 0.57%
9,559 $2.99 Million
Q1 2024

Apr 12, 2024

SELL
$268.87 - $324.56 $29,575 - $35,701
-110 Reduced 1.13%
9,614 $2.73 Million
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $25,058 - $28,269
-98 Reduced 1.0%
9,724 $2.8 Million
Q3 2023

Oct 16, 2023

SELL
$218.65 - $271.46 $47,884 - $59,449
-219 Reduced 2.18%
9,822 $2.64 Million
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $53,567 - $63,342
-250 Reduced 2.43%
10,041 $2.23 Million
Q1 2023

Apr 10, 2023

SELL
$225.79 - $275.2 $48,544 - $59,168
-215 Reduced 2.05%
10,291 $2.49 Million
Q4 2022

Jan 17, 2023

SELL
$229.03 - $291.01 $8,474 - $10,767
-37 Reduced 0.35%
10,506 $2.76 Million
Q3 2022

Oct 20, 2022

BUY
$224.46 - $253.15 $9,651 - $10,885
43 Added 0.41%
10,543 $2.38 Million
Q2 2022

Jul 26, 2022

SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 0.28%
10,500 $2.56 Million
Q1 2022

Apr 25, 2022

BUY
$219.27 - $242.57 $43,854 - $48,514
200 Added 1.94%
10,530 $2.55 Million
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $14,916 - $17,070
75 Added 0.73%
10,330 $2.32 Million
Q2 2021

Jul 14, 2021

BUY
$233.58 - $259.14 $146,221 - $162,221
626 Added 6.5%
10,255 $2.5 Million
Q4 2020

Jan 12, 2021

SELL
$216.38 - $257.67 $52,363 - $62,356
-242 Reduced 2.45%
9,629 $2.21 Million
Q2 2020

Jul 07, 2020

BUY
$197.81 - $242.74 $44,507 - $54,616
225 Added 2.33%
9,871 $2.33 Million
Q1 2020

Apr 08, 2020

BUY
$182.24 - $241.7 $4,738 - $6,284
26 Added 0.27%
9,646 $1.96 Million
Q3 2019

Oct 10, 2019

BUY
$174.11 - $208.62 $19,152 - $22,948
110 Added 1.16%
9,620 $1.86 Million
Q1 2019

Apr 04, 2019

SELL
$180.87 - $203.88 $10,852 - $12,232
-60 Reduced 0.63%
9,510 $1.81 Million
Q4 2018

Jan 14, 2019

BUY
$178.4 - $208.25 $21,229 - $24,781
119 Added 1.26%
9,570 $1.86 Million
Q3 2018

Oct 09, 2018

BUY
$185.29 - $208.89 $19,270 - $21,724
104 Added 1.11%
9,451 $1.96 Million
Q2 2018

Jul 10, 2018

BUY
$166.05 - $186.51 $142,803 - $160,398
860 Added 10.13%
9,347 $1.73 Million
Q1 2018

Apr 09, 2018

BUY
$169.43 - $198.0 $7,624 - $8,910
45 Added 0.53%
8,487 $1.45 Million
Q4 2017

Jan 11, 2018

SELL
$168.79 - $188.59 $74,773 - $83,545
-443 Reduced 4.99%
8,442 $1.47 Million
Q3 2017

Oct 13, 2017

BUY
$167.29 - $191.0 $1.49 Million - $1.7 Million
8,885
8,885 $1.66 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Premier Bank Portfolio

Follow First Premier Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.